| Ytd | 131.01% | |
| 1y | 172.53% |
| Open | 21.53 | Prev Close | 21.53 | Low | 21.53 | High | 21.53 | Mkt Cap | 2.22B |
| Vol | 0.00 | Avg Vol | 4.01M | EPS | -1.04 | P/E | -20.70 | Forward P/E | -177.57 |
| Beta | -1.74 | Short Ratio | 2.79 | Inst. Own | 83.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 18.21 | 200-d Avg | 10.72 | 1yr Est | 21.50 |
DAWN News
Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN - Get Free Report)'s share price reached a new 52-wee
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and
Day One Biopharmaceuticals (NASDAQ: DAWN) executives highlighted accelerating commercial momentum fo
Wall Street analysts change outlook on top stocks. Check analyst ratings page for upgrades, downgrad
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Day One's stock surges 66% after Servier agrees to acquire it for $21.50 per share in a $2.5B deal,
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
The S&P 500 (^GSPC 1.33%) fell 1.33% to 6,740.02, the Nasdaq Composite (^IXIC 1.59%) slid 1.59% to 2
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 6, 2026) - Law office of Brodsky & Smith announce
MILWAUKEE, March 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Day One (NASDAQ: DAWN) for possi
NEW YORK, March 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Dow Jones falls 500 points on Friday, Marvell Technology shares jump 18.4%, other stocks recording g
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares are trading higher Friday after the company a
Stocks down, Nasdaq falls 300+ points. Dow down 1.62%, Nasdaq down 1.47%, S&P 500 down 1.38%. En
Independent international pharmaceutical group Servier will buy Day One Biopharmaceuticals fo
SURESNES, France and BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Servier, an independent in
Day One Biopharmaceuticals is maintained at a "Strong Buy" rating, driven by robust pipeline progres
Day One Biopharmaceuticals, Inc.'s Q4 '25 came with net product revenues of $52.8M, up 36% from the
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on
U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on
U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling by more than 400
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the com
On Friday, 153 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 166 companies set new 52-week lows.
On Thursday, 112 stocks made new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.